Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Katrina Spensley"'
Autor:
Tina Thomson, Maria Prendecki, Sarah Gleeson, Paul Martin, Katrina Spensley, Rute Cardoso De Aguiar, Bynvant Sandhu, Charlotte Seneschall, Jaslyn Gan, Candice L. Clarke, Shanice Lewis, Graham Pickard, David Thomas, Stephen P. McAdoo, Liz Lightstone, Alison Cox, Peter Kelleher, Michelle Willicombe
Publikováno v:
EClinicalMedicine, Vol 53, Iss , Pp 101642- (2022)
Summary: Background: Solid organ transplant recipients have attenuated immune responses to SARS-CoV-2 vaccines. In this study, we report on immune responses to 3rd- (V3) and 4th- (V4) doses of heterologous and homologous vaccines in a kidney transpla
Externí odkaz:
https://doaj.org/article/4879b50c9f754096b64b6ff9caf5fbc2
Autor:
Paul Martin, Sarah Gleeson, Candice L. Clarke, Tina Thomson, Helena Edwards, Katrina Spensley, Paige Mortimer, Stacey McIntyre, Alison Cox, Graham Pickard, Liz Lightstone, David Thomas, Stephen P. McAdoo, Peter Kelleher, Maria Prendecki, Michelle Willicombe
Publikováno v:
The Lancet Regional Health. Europe, Vol 21, Iss , Pp 100478- (2022)
Summary: Background: People with end-stage kidney disease, including people on haemodialysis, are susceptible to greater COVID-19 related morbidity and mortality. This study compares the immunogenicity and clinical effectiveness of BNT162B2 versus Ch
Externí odkaz:
https://doaj.org/article/dca0c46f18974f1b8561576518435e95
Autor:
Tina Thomson, Maria Prendecki, Sarah Gleeson, Paul Martin, Katrina Spensley, Charlotte Seneschall, Jaslyn Gan, Candice L. Clarke, Shanice Lewis, Graham Pickard, David Thomas, Stephen P. McAdoo, Liz Lightstone, Alison Cox, Peter Kelleher, Michelle Willicombe
BackgroundSolid organ transplant recipients have attenuated immune responses to SARS-CoV-2 vaccines. Emerging evidence suggests at least equivalent immunogenicity of heterologous compared with homologous vaccine regimens in the general population. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af50881d8d793649305e27f6808a37ef
https://doi.org/10.1101/2022.01.25.22269778
https://doi.org/10.1101/2022.01.25.22269778
Autor:
Katrina Spensley, Sarah Gleeson, Paul Martin, Tina Thomson, Candice L. Clarke, Graham Pickard, David Thomas, Stephen P. McAdoo, Paul Randell, Peter Kelleher, Rachna Bedi, Liz Lightstone, Maria Prendecki, Michelle Willicombe
BackgroundEmerging data suggest a reduction in SARS-CoV-2 vaccine effectiveness against Omicron SARS-CoV-2 infection. There is also evidence to show that Omicron is less pathogenic than previous variants. For clinically vulnerable populations, a less
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f2794fb4de391b3b830aeb025d61814
https://doi.org/10.1101/2022.01.25.22269804
https://doi.org/10.1101/2022.01.25.22269804